Clinically suspected myocarditis in COVID‐19 patients: Case series and review of the literature

This Study describes eleven patients positive for severe acute respiratory syndrome coronavirus 2. In our cases, females and younger patients developed more severe disease. In contrast, improvement in left ventricular ejection fraction and N‐terminal prohormone brain natriuretic peptide within the f...

Full description

Saved in:
Bibliographic Details
Published in:Clinical case reports 2021-12, Vol.9 (12), p.e05236-n/a
Main Authors: Amin, Ahmad, Eftekhar, Seyed Parsa, Ziaie, Naghmeh, Roudbari, Soudeh, Salehi, Pegah, Jalali, Farzad, Jafaripour, Iraj, Ghaffari, Sanaz, Mohseni Salehi, Maryam, Ebadi, Reza
Format: Article
Language:English
Subjects:
Antibiotics
Blood pressure
Body temperature
Cardiac arrhythmia
Cardiomyocytes
Case Report
Case reports
Consciousness
Coronaviruses
COVID-19
Dyspnea
echocardiography
Ejection fraction
Electrocardiography
Enzymes
Fainting
Fever
Heart rate
Hemoglobin
Laboratories
Medical imaging
Myocarditis
NT‐proBNP
Pain
Patients
SARS‐CoV‐2
Severe acute respiratory syndrome coronavirus 2
Sinuses
Steroids
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This Study describes eleven patients positive for severe acute respiratory syndrome coronavirus 2. In our cases, females and younger patients developed more severe disease. In contrast, improvement in left ventricular ejection fraction and N‐terminal prohormone brain natriuretic peptide within the first week of treatment contributed to promising outcomes. Although it seems that COVID‐19 myocarditis is not a common complication, its lethal nature makes it essential to carefully monitor patients for possible clinical and laboratory findings of myocarditis (especially females and younger ages).
ISSN:2050-0904
2050-0904
DOI:10.1002/ccr3.5236